Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial of Adjunctive Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Renal Failure [MERIT] MyEloma Renal Impairment Trial

NCT00416897 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT00416897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00416897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial of Adjunctive Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Renal Failure [MERIT] MyEloma Renal Impairment Trial
Lead sponsor
University of Glasgow
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2003
Completion date
December 31, 2008
Enrollment
280 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm, renal failure